Drug Profile
Pegylated urofollitropin - PharmaEssentia
Alternative Names: PEG-FSH - PharmaEssentiaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator PharmaEssentia Corporation
- Class Follicle stimulating hormones; Infertility therapies; Menotropins; Pituitary gonadotropins
- Mechanism of Action Follicle stimulating hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Infertility
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for preclinical development in Infertility in Taiwan (Parenteral)
- 31 Dec 2014 Preclinical trials in Infertility in Taiwan (Parenteral)